Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients

Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients

Background: Fosaprepitant-associated injection site reaction (ISR) has been reported in patients treated with cisplatin, an irritant drug. We conducted this retrospective study to clarify the incidence and symptoms of fosaprepitant-associated ISR in patients treated with anthracycline.

Bibliographic Details
Main Authors: Sato, Yumiko, Kondo, Masahiro, Inagaki, Atsushi, Komatsu, Hirokazu, Okada, Chika, Naruse, Kumi, Sahashi, Tomoyo, Kuroda, Junko, Ogura, Hiroka, Uegaki, Shiori, Yoshida, Tatsuya, Mori, Yoshinori, Sawada, Hiroo, Watanabe, Shoichi, Sugiura, Hiroshi, Endo, Yumi, Yoshimoto, Nobuyasu, Toyama, Tatsuya, Iida, Shinsuke, Yamada, Koichi, Kimura, Kazunori, Wakita, Atsushi
Format: Online
Language:English
Published: Ivyspring International Publisher 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007527/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007527/

Similar Items